MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease
Launched by KING'S COLLEGE LONDON · Nov 8, 2010
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Angina pectoris CCS class II and III and either
- • ≥2 cardiovascular risk factors
- • or positive exercise treadmill test
- • Signed written informed consent
- • age: at least 18 years
- Exclusion Criteria:
- • contraindication to MR
- • contraindication to adenosine infusion
- • EF≤ 30%
- • inability to lie supine for 60 minutes
- • previous Coronary Artery Bypass Grafts
- • revascularization within the previous 6 months
- • cardiac arrhythmias (atrial fibrillation, \>20 ectopic beats/min)
- • poor renal function (eGFR \<30ml/min)
- • body weight \> 140kg or waist perimeter \> 95cm
- • known allergy to contrast media
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Eike Nagel, MD, PhD
Principal Investigator
Goethe University Frankfurt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials